Viral Vector Manufacturing Market Scope, Analysis, and Trends by 2030
Viral Vector Manufacturing Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 1.29 Billion |
Market Size by 2030 | US$ 5.00 Billion |
Global CAGR (2022 - 2030) | 18.4% |
Historical Data | 2020-2022 |
Forecast period | 2022-2030 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
Competitive Landscape and Key Companies:
Charles River Laboratories, Merck KGaA, Biovian Oy, Global Life Sciences Solutions USA LLC, Lonza Group Ltd, Creative Biogene, VIVEbiotech SL, Genezen Laboratories Inc, GenScript Biotech Corporation, and AGC Biologics are among the prominent players operating in the viral vector manufacturing market. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios.